BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27927168)

  • 21. Phosphodiesterase regulation of alcohol drinking in rodents.
    Logrip ML
    Alcohol; 2015 Dec; 49(8):795-802. PubMed ID: 26095589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic AMP-dependent Cl secretion is regulated by multiple phosphodiesterase subtypes in human colonic epithelial cells.
    O'Grady SM; Jiang X; Maniak PJ; Birmachu W; Scribner LR; Bulbulian B; Gullikson GW
    J Membr Biol; 2002 Jan; 185(2):137-44. PubMed ID: 11891572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family.
    Gibson LC; Hastings SF; McPhee I; Clayton RA; Darroch CE; Mackenzie A; Mackenzie FL; Nagasawa M; Stevens PA; Mackenzie SJ
    Eur J Pharmacol; 2006 May; 538(1-3):39-42. PubMed ID: 16674936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
    Butt E; Beltman J; Becker DE; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
    Mol Pharmacol; 1995 Feb; 47(2):340-7. PubMed ID: 7870042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
    Lugnier C; Keravis T; Eckly-Michel A
    J Physiol Pharmacol; 1999 Dec; 50(4):639-52. PubMed ID: 10639014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: differential regulation in cobblestone and spindle phenotypes.
    Keravis T; Komas N; Lugnier C
    J Vasc Res; 2000; 37(4):235-49. PubMed ID: 10965223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
    Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
    J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
    Lugnier C; Komas N
    Eur Heart J; 1993 Nov; 14 Suppl I():141-8. PubMed ID: 8293765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
    Matthiesen K; Nielsen J
    Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphodiesterases in neurodegenerative disorders.
    Bollen E; Prickaerts J
    IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 33. Folate status and S-adenosylmethionine/S-adenosylhomocysteine ratio in colorectal adenocarcinoma in humans.
    Alonso-Aperte E; González MP; Póo-Prieto R; Varela-Moreiras G
    Eur J Clin Nutr; 2008 Feb; 62(2):295-8. PubMed ID: 17375119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
    Lugnier C
    Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
    Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterases and cyclic GMP regulation in heart muscle.
    Lee DI; Kass DA
    Physiology (Bethesda); 2012 Aug; 27(4):248-58. PubMed ID: 22875455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitotic and apoptotic activity in colorectal neoplasia.
    Kohoutova D; Pejchal J; Bures J
    BMC Gastroenterol; 2018 May; 18(1):65. PubMed ID: 29776402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular implications in the use of PDE5 inhibitor therapy.
    Maurice DH
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S20-3. PubMed ID: 15224131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.